Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,

    Anti-Infectives Knowledge Network (AIKN) CDI Updates

    Recently updated with ISICEM 2015 presentations, data from the largest ever European
    clinician consensus report, as well as key perspectives on Clostridium difficile infection
    The Anti-Infectives Knowledge Network shares expertise and experience in the area of

    This educational resource is an initiative by Astellas Pharma EMEA. Please remember
    to return often to read the news, clinical insights, and essential information from the
    latest anti-infectives congresses.

    March 2015 FDX/15/0024/EUb

  • ,

    New Therapy Focus area for
    type 2 diabetes launched

    This free resource has recently launched on epgonline.org containing information
    for healthcare professionals based in Europe on the use of incretin‐insulin treatment
    combinations for type 2 diabetes. Explore five informative sections focused on the role
    emerging incretin‐based therapies can play in the long‐term treatment and management of
    type 2 diabetes.

  • ,Whats's New Diabetes Knowledge Centre Relaunch

    Updated Type 2 Diabetes Mellitus Knowledge Centre

    Explore new information added to the diagnosis and treatment sections of the
    Type 2 Diabetes Mellitus Knowledge Centre with recommendations on the appropriate
    management of the condition. A brand new guidelines section is also available,
    containing the latest recommendations from ADA, EASD and NICE.

  • ,What's New Hypogonadism

    Hypogonadism Knowledge Centre

    epgonline.org’s Hypogonadism Knowledge Centre features a publications digest section,
    regularly updated with analysis and comment on recent scientific articles related to male

    Found within the Men’s Health/Andrology disease topic homepage, users can also access
    information on the prevalence, diagnosis and available treatment options for male

  • ,What's New Obesity 2 and 3

    New modules added to Obesity CME series

    Two new modules have been added to the EACCME-accredited European Obesity Initiative
    CME series.

    'Understanding Obesity' is already available for healthcare professionals looking to improve
    their understanding of obesity as a serious medical illness. Modules 2 and 3 focus
    on the pharmacological considerations and rationale for lifelong behaviour change.
    A combined total of 5 European CME credits (ECMECs) are available on successful
    completion of this free CME series.

Latest News

FDA approves Corlanor (ivabradine)to treat heart failure-Amgen


Amgen announced that the FDA has granted approval of Corlanor (ivabradine), an oral medication indicated to reduce the risk of hospitalization for worsening heart failure in patients with stable, symptomatic chronic heart failure with left ...

TASQ (tasquinimod) discontinued for Prostate Cancer-Active Biotech/Ipsen


Active Biotech and Ipsen announced top line results of the 10TASQ10 study. While the study showed that TASQ (tasquinimod) reduced the risk of radiographic cancer progression or death compared to placebo (rPFS, HR=0.69, CI 95%: 0.60 - 0.80) in ...

Study of HeartWare Ventricular Assist System in Heart Failure meets primary endpoint-HeartWare


HeartWare International has announced that data from its first destination therapy clinical trial cohort, ENDURANCE, successfully demonstrated that the trial achieved the primary endpoint. HeartWare's ENDURANCE clinical trial is a prospective, ...

BMS transfers rights to Erbitux (cetuximab) in US, Puerto Rico and Canada to Eli Lilly.


Eli Lilly and Company and Bristol-Myers Squibb Company have announced that the companies have agreed to transfer rights to Erbitux (cetuximab) in North America, including the U.S., Canada, and Puerto Rico, from Bristol-Myers Squibb to Lilly. ...

Updates to Anti-Infectives Knowledge Network-CDI


​ The Anti-Infectives Knowledge Network – Clostridium difficile infections (AIKN-CDI), an initiative by Astellas Pharma EMEA, has recently been updated with new content. New features on the site include data presentations from the 35th ISICEM, ...

COMPLEMENT 1 study of Arzerra (ofatumumab)+ chlorambucil positive results published in The Lancet-Novartis


Phase III data published in The Lancet showed that treatment with Arzerra (ofatumumab), from Novartis, plus chlorambucil, a chemotherapy, resulted in a statistically significant improvement in progression free survival (PFS) versus chlorambucil ...

Success for Ibrance (palbociclib)+ fulvestrant in PALOMA-3 trial for metastatic breast cancer- Pfizer


Pfizer Inc. announced that the Phase III PALOMA-3 trial for Ibrance (palbociclib) met its primary endpoint of demonstrating an improvement in progression-free survival (PFS) for the combination of Ibrance plus fulvestrant( Faslodex) compared with ...

Recent Updates


Clinical Guidelines

Guidelines on Muscle-invasive and Metastatic Bladder Cancer

Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline

Guidelines on Urological Infections

Guidelines on Testicular Cancer

Medical Journals

MAP Kinase Phosphatase 2 Regulates Macrophage-Adipocyte Interaction.

Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies.

Assessment of psychological predictors of weight loss: How and what for?

Obesity Impairs γδ T Cell Homeostasis and Antiviral Function in Humans.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages



News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors